- Tytuł:
- Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
- Autorzy:
- Źródło:
- In The Lancet Oncology April 2015 16(4):447-456
Czasopismo naukowe